Dr. Amber Wheeler discusses the beauty breathing technique that could be the solution to snoring and other breathing abnormalities during sleep.

Creates New Revenue Opportunities for Medical Prescribers and Provides Continuous and Personalized Patient Data LAS VEGAS, Jan. 6, 2025 /PRNewswire-PRWeb/ -- Dianyx Innovations is set to make ...

Her work has appeared in Women's Health, SELF, Prevention, The Washington Post, and more. Sleep apnea impacts about 30 million American adults, making it a common sleep disorder. But while plenty ...

The Food and Drug Administration (FDA) on Dec. 20 approved the obesity medication Zepbound (tirzepatide) as the first pharmaceutical treatment for moderate-to-severe obstructive sleep apnea (OSA ...

The Food and Drug Administration approved Eli Lilly’s weight-loss drug Zepbound on Dec. 27 to treat sleep apnea, a common but potentially serious sleep-related breathing disorder, making it the ...

Oral appliances can provide a comfortable and effective solution for sleep apnea. But there are several types of appliances, and they offer a range of benefits — here’s how to find what you need.

The U.S. Food and Drug Administration (FDA) has granted approval for Zepbound, a weight-loss medication, to treat moderate to severe obstructive sleep apnea (OSA) in individuals with obesity.

(Getty Images) (NewsNation) — Zepbound became the first drug approved by the Food and Drug Administration to treat obstructive sleep apnea in obese adults earlier this month. “This is a major step ...

And the discourse is ongoing, with Israeli public health experts and some parents agitating for fluoride to be reinserted in the water — citing worsening dental outcomes for children — at the ...

The FDA approved Zepbound (tirzepatide) as the first prescription medication specifically for adults with moderate-to-severe obstructive sleep apnea (OSA) and obesity. People taking Zepbound lost ...

The first medication for obstructive sleep apnea has been approved by the US Food and Drug Administration (FDA). On Dec. 20, the FDA announced that the agency has approved Eli Lilly’s Zepbound ...